130 related articles for article (PubMed ID: 22970737)
1. Effects on routine coagulation screens and assessment of anticoagulant intensity in patients taking oral dabigatran or rivaroxaban: guidance from the British Committee for Standards in Haematology.
Baglin T; Keeling D; Kitchen S;
Br J Haematol; 2012 Nov; 159(4):427-9. PubMed ID: 22970737
[No Abstract] [Full Text] [Related]
2. Clinical review: Clinical management of new oral anticoagulants: a structured review with emphasis on the reversal of bleeding complications.
Lazo-Langner A; Lang ES; Douketis J
Crit Care; 2013 Jun; 17(3):230. PubMed ID: 23806169
[TBL] [Abstract][Full Text] [Related]
3. The new oral anticoagulants and the future of haemostasis laboratory testing.
Favaloro EJ; Lippi G
Biochem Med (Zagreb); 2012; 22(3):329-41. PubMed ID: 23092064
[TBL] [Abstract][Full Text] [Related]
4. Management of dabigatran-induced bleeding: expert statement.
Fries D; Giurea A; Gütl M; Halbmayer WM; Kozek-Langenecker S; Pachucki A; Roithinger F; Steinlechner B; Thaler H; Weltermann A
Wien Klin Wochenschr; 2013 Nov; 125(21-22):721-9. PubMed ID: 24217941
[TBL] [Abstract][Full Text] [Related]
5. Magnetic coagulometry: towards a new nanotechnological tool for
Santana-Otero A; Harper A; Telling N; Ortega D; Cabrera D
Nanoscale; 2024 Feb; 16(7):3534-3548. PubMed ID: 38285061
[TBL] [Abstract][Full Text] [Related]
6. Pathophysiology, diagnosis and management of cerebral venous thrombosis: A comprehensive review.
Ranjan R; Ken-Dror G; Sharma P
Medicine (Baltimore); 2023 Dec; 102(48):e36366. PubMed ID: 38050259
[TBL] [Abstract][Full Text] [Related]
7. Generic Methods for Simultaneous Analysis of Four Direct Oral Anticoagulants in Human Plasma and Urine by Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry.
Ren JW; Zheng X; Han XH
Molecules; 2023 Feb; 28(5):. PubMed ID: 36903499
[TBL] [Abstract][Full Text] [Related]
8. "Accessory After the Factors": A Rare Case of an Acquired Factor VIII Inhibitor in a 75-Year-Old Man on Rivaroxaban.
Gutierrez N; Park J; Leighton T
Cureus; 2021 Oct; 13(10):e18597. PubMed ID: 34765360
[TBL] [Abstract][Full Text] [Related]
9. Direct oral anticoagulants (DOACs) and neck of femur fractures: Standardising the perioperative management and time to surgery.
Shah R; Sheikh N; Mangwani J; Morgan N; Khairandish H
J Clin Orthop Trauma; 2021 Jan; 12(1):138-147. PubMed ID: 33716439
[TBL] [Abstract][Full Text] [Related]
10. D-dimer Level is Correlated with Prognosis, Infarct Size, and NIHSS in Acute Ischemic Stroke Patients
Abbas NI; Sayed O; Samir S; Abeed N
Indian J Crit Care Med; 2021 Feb; 25(2):193-198. PubMed ID: 33707899
[TBL] [Abstract][Full Text] [Related]
11. Deep Venous Thrombosis in a Patient with a Moderate Pretest Probability and a Negative D-Dimer Test: A Review of the Diagnostic Algorithms.
Al-Khafaji RA; Schierbeck L
J Blood Med; 2020; 11():173-184. PubMed ID: 32581617
[TBL] [Abstract][Full Text] [Related]
12. Chromogenic anti-FXa assay calibrated with low molecular weight heparin in patients treated with rivaroxaban and apixaban: possibilities and limitations.
Margetić S; Ćelap I; Delić Brkljačić D; Pavlović N; Šupraha Goreta S; Kobasić I; Lovrenčić-Huzjan A; Bašić Kes V
Biochem Med (Zagreb); 2020 Feb; 30(1):010702. PubMed ID: 31839722
[TBL] [Abstract][Full Text] [Related]
13. NOACs in Anesthesiology.
Spahn DR; Beer JH; Borgeat A; Chassot PG; Kern C; Mach F; Nedeltchev K; Korte W
Transfus Med Hemother; 2019 Aug; 46(4):282-293. PubMed ID: 31700511
[TBL] [Abstract][Full Text] [Related]
14. The In Vitro Effects of Pentamidine Isethionate on Coagulation and Fibrinolysis.
Al-Horani RA; Clemons D; Mottamal M
Molecules; 2019 Jun; 24(11):. PubMed ID: 31174390
[TBL] [Abstract][Full Text] [Related]
15. Patients on NOACs in the Emergency Room.
Gerner ST; Huttner HB
Curr Neurol Neurosci Rep; 2019 May; 19(7):40. PubMed ID: 31144111
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic accuracy of thromboelastometry and its correlation with the HPLC-MS/MS quantification test.
Aranda VF; Derogis PBM; Sanches LR; Mangueira CLP; Katz M; Faulhaber ACL; Mendes CEA; Ferreira CEDS; França CN; Guerra JCC
Braz J Med Biol Res; 2019 Apr; 52(4):e8006. PubMed ID: 30970082
[TBL] [Abstract][Full Text] [Related]
17. Routine Coagulation Tests in Patients With Nonvalvular Atrial Fibrillation Under Dabigatran and Rivaroxaban Therapy: An Affordable and Reliable Strategy?
Silva VM; Scanavacca M; Darrieux F; Cavalheiro C; Strunz CC
Clin Appl Thromb Hemost; 2019; 25():1076029619835053. PubMed ID: 30907118
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of global laboratory methods and establishing on-therapy ranges for monitoring apixaban and rivaroxaban: Experience at a single institution.
Park SH; Seo YH; Park PW; Kim KH; Seo JY; Lee HT; Kwoun WJ; Ahn JY
J Clin Lab Anal; 2019 Jun; 33(5):e22869. PubMed ID: 30860622
[TBL] [Abstract][Full Text] [Related]
19. Measurement of coagulation factors during rivaroxaban and apixaban treatment: Results from two crossover trials.
Scheres LJJ; Lijfering WM; Middeldorp S; Cheung YW; Barco S; Cannegieter SC; Coppens M
Res Pract Thromb Haemost; 2018 Oct; 2(4):689-695. PubMed ID: 30349888
[TBL] [Abstract][Full Text] [Related]
20. Safety of 4-factor prothrombin complex concentrate (4F-PCC) for emergent reversal of factor Xa inhibitors.
Tao J; Bukanova EN; Akhtar S
J Intensive Care; 2018; 6():34. PubMed ID: 29942519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
